FIELD: medicine.
SUBSTANCE: method is proposed for in vitro determination of Helicobacter pylori (Hp) in a biological sample isolated from an individual and determination of the resistance of the specified Hp to clarithromycin, including amplification of at least one part of at least one Hp gene containing at least one site of the mutation responsible for clarithromycin resistance, where the above-noted mutation is selected from A2143G, A2142C and A2142G for the 23S rRNA gene. A kit is proposed for determining Hp in a fecal sample isolated from an individual and determining the resistance of this Hp to clarithromycin caused by a mutation of 23S rRNA gene selected from the group consisting of A2143G, A2142C and A2142G.
EFFECT: proposed group of inventions provides a specific determination of the presence of Hp infection and Hp resistance to clarithromycin. Proposed group of inventions provides a specific determination of the presence of Hp infection and Hp resistance to clarithromycin.
6 cl, 1 dwg, 5 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING HELICOBACTER PYLORI INFECTION AND ITS RESISTANCE TO CLARITHROMYCIN AND LEVOFLOXACIN | 2022 |
|
RU2806581C1 |
| METHOD FOR DETECTING THE PRESENCE OF MUTATIONS LEADING TO MYCOPLASMA GENITALIUM RESISTANCE TO MACROLIDE AND FLUOROQUINOLONE ANTIBIOTICS | 2019 |
|
RU2725477C1 |
| OLIGONUCLEOTIDE BIOCHIP FOR IDENTIFICATION OF GENETIC DETERMINANT OF NEISSERIA GONORRHOEAE RESISTANCE TO ANTIMICROBIAL PREPARATIONS, SET OF OLIGONUCLEOTIDES USED FOR IMMOBILISATION ON BIOCHIP | 2016 |
|
RU2636457C2 |
| METHOD OF DETECTION OF MYCOBACTERIUM RESISTANCE TO RIFAMPICIN WITH THEIR POSSIBLE IDENTIFICATION, METHOD OF HYBRIDIZATION, PROBE AND COMPOSITION FOR ITS REALIZATION, SET OF PRIMERS (VARIANTS) | 1995 |
|
RU2204608C2 |
| DNA-CHIP FOR IDENTIFYING GENETIC DETERMINANT OF ANTIBIOTIC RESISTANCE OF INFECTIOUS AGENTS LEADING TO DISTURBED HUMAN REPRODUCTIVE FUNCTIONS, KIT OF OLIGONUCLEOTIDES FOR IMMOBILIZATION ON DNA-CHIP | 2016 |
|
RU2685188C2 |
| METHOD OF ANALYZING POLYMORPHIC MARKERS IN THE GENES VKORC1, CYP4F2, CYP2C9, CYP2C19, ABCB1, ITGB3 TO DETERMINE INDIVIDUAL SENSITIVITY TO ANTICOAGULANT DRUGS | 2018 |
|
RU2689400C1 |
| GENETIC MARKERS FOR PREDICTION OF SUSCEPTIBILITY TO THERAPY | 2014 |
|
RU2707533C2 |
| METHOD FOR IDENTIFYING MUTATIONS IN THE GENE OF PENICILLIN-BINDING PROTEIN 2 PENA NEISSERIA GONORRHOEAE, LEADING TO RESISTANCE TO BETA-LACTAM ANTIBIOTICS, ON BIOLOGICAL MICROCHIPS | 2020 |
|
RU2741099C1 |
| NEW PRIMERS FOR SCREENING OF SCHIZOPHRENIA AND METHOD OF ITS SCREENING | 2002 |
|
RU2338788C2 |
| METHOD OF POLYMORPHIC MARKERS ANALYSIS IN THE GENES OF METABOLISM OF MEDICINAL PREPARATIONS AND THE GENES OF IMMUNE RESPONSE IN THE ACUTE LEUCOSISES THERAPY IN CHILDREN | 2016 |
|
RU2643333C1 |
